IQI
RIGL icon

Integrated Quantitative Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Integrated Quantitative Investments’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,135
Closed -$220K – 502
2026
Q1 		$220K Hold
8,135
– – 0.04% 369
2025
Q4 		$348K Sell
8,135
-2,465
-23% -$92.9K 0.07% 306
2025
Q3 		$300K Sell
10,600
-42
-0.4% -$1.26K 0.09% 267
2025
Q2 		$199K Sell
10,642
-39
-0.4% -$739 0.06% 356
2025
Q1 		$192K Sell
10,681
-78
-0.7% -$1.58K 0.09% 265
2024
Q4 		$181K Buy
+10,759
New +$206K 0.09% 282

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Quantitative Investments's RIGL Position: Q2 2026 in Review

Integrated Quantitative Investments sold out of Rigel Pharmaceuticals (RIGL) in Q2 2026, closing a stake of 8,135 shares — an estimated $220K sold.

Integrated Quantitative Investments first reported a position in RIGL in Q4 2024 and held it in 6 quarters. The position peaked at $348K in Q4 2025. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Integrated Quantitative Investments reported no remaining Rigel Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 8,135 Rigel Pharmaceuticals shares in Q2 2026, an estimated $220K.
  • Integrated Quantitative Investments first reported a position in Rigel Pharmaceuticals in Q4 2024 and held it in 6 quarters.
  • Integrated Quantitative Investments's Rigel Pharmaceuticals position peaked at $348K in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.